Evidence map›Paper›PMID 6488673›Full record

ArticleClinics in perinatology1984

Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn.

T J Kulik, J E Lock

Open access · greenAbstract read
In one paragraph

Article in Clinics in perinatology, 1984. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

T J Kulik
J E Lock
Harvard University · US

Funding

AMP Kinase regulation in persistent pulmonary hypertension of the newbornR01HL136597 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI KONDURI, GIRIJA G. · 2018 to 2021
$1.5M
NHLBI NIH HHS R01 HL136597
6 · The paper itself

Abstract

A review of the physiology of persistent pulmonary hypertension of the newborn is provided, followed by a critical review of many of the agents that have been employed to treat this condition. In addition, the authors speculate on what type of pharmacologic therapy may prove useful in the future.

Indexed as

AcetylcholineAminopyridinesAmrinoneBradykininChlorpromazineHumansInfant, NewbornIsoproterenolLungNitroprussidePersistent Fetal Circulation SyndromeProstaglandinsTolazolineVascular ResistanceVasoconstrictionVasodilator AgentsAcetylcholineAminopyridinesAmrinoneBradykininChlorpromazineIsoproterenolNitroprussideProstaglandinsTolazolineVasodilator Agents

Identifiers

PMID6488673
PMCPMC8885147
OpenAlexW196511877

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.